Calidi Biotherapeutics, Inc. Current Assets
Calidi Biotherapeutics, Inc. (CLDI) had Current Assets of $5.43 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $5.43M.
- 2026-03-31: Assets, Current $7.35M.
- 2025-12-31: Assets, Current $6.26M.
- 2025-09-30: Assets, Current $11.03M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $5.43M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $7.35M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $6.26M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $11.03M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $6.05M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $11.49M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $10.23M 10-K · filed 2026-03-27 | |
| 2024-09-30 | $2.22M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.63M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $1.94M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $4.30M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $11.69M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $795.48K 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $268.86K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $786.00K 10-K · filed 2024-03-15 | $401.67K 10-K · filed 2023-03-31 |
| 2022-09-30 | $479.09K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $759.67K 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $1.03M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $1.48M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $2.00M 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |